Advances in the study of corticoid and melatonin in circadian rhythm disorders of oncology patients
DOI:
https://doi.org/10.54097/hset.v36i.5675Keywords:
Circadian Rhythm Disorders, Cancer, Corticoids, Melatonin, Oncogene, Treatment.Abstract
It has been increasingly common to be diagnosed with cancer in recent years. In addition to cancer itself, which torments the patient and impairs body functions, oncology patients may develop many complications, and sleep disorders are one of them. Sleep disorders that are found in tumor survivors including sleep related breathing disorders, sleep related movement disorders, parasomnias, central disorders of hypersomnolence, insomnia and circadian rhythm sleep-wake disorders (CRSWDs). It has been proved that tumors are the cause of sleep disorders, but the mechanism underlying them remains unknown. Therefore, the study of the mechanism of sleep disorders in oncology patients has become very popular among researchers today. A wide range of systemic tumors, including brain tumor, pancreatic cancer, colon cancer, lung cancer, renal tumor and so on have a mutation of RAS or MYC, which may cause circadian rhythm disorders through some changes on Clock genes in the body. This review will focus on whether different tumors follow the same mechanism causing circadian rhythm disorders. Whether Melatonin and Cognitive Behavioral Therapy (CBT) are efficient in treating post-cancer sleep disorders in clinical trials will also be introduced.
Downloads
References
Siegel R L, Miller K D, Fuchs H E, et al. Cancer statistics, 2021. CA: A cancer journal for Clinicians, 2021, 71(1): 7–33
Matthews E E, Wang S-Y. Cancer-related sleep wake disturbances. Seminars in Oncology Nursing, 2022, 38(1): 151253
Cho S, Lee J, Lim J, et al. Pruritus in patients under targeted anticancer therapy: a multidimensional analysis using the 5-d itch scale. Acta Dermato Venereologica, 2019, 99(4): 435–441
Savard J, Ivers H, Savard M-H, et al. Cancer treatments and their side effects are associated with aggravation of insomnia: results of a longitudinal study. Cancer, 2015, 121(10): 1703–1711
Willis K D, Ravyts S G, Lanoye A, et al. Sleep disturbance in primary brain tumor: prevalence, risk factors, and patient preferences. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 2022, 30(1): 741–748
Walker W H, Borniger J C. Molecular mechanisms of cancer-induced sleep disruption. International Journal of Molecular Sciences, 2019, 20(11): E2780
Chan S, Debono M. Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy. Therapeutic Advances in Endocrinology and Metabolism, 2010, 1(3): 129–138
Masri S, Sassone-Corsi P. The emerging link between cancer, metabolism, and circadian rhythms. Nature Medicine, 2018, 24(12): 1795–1803
Miller A H, Ancoli-Israel S, Bower J E, et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 2008, 26(6): 971–982
Rao R T, Scherholz M L, Androulakis I P. Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis. Chronobiology International, 2018, 35(12): 1619–1636
Fukuoka H, Shichi H, Yamamoto M, et al. The mechanisms underlying autonomous adrenocorticotropic hormone secretion in cushing’s disease. International Journal of Molecular Sciences, 2020, 21(23): E9132
Debono M, Harrison R F, Chadarevian R, et al. Resetting the abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion. The Journal of Clinical Endocrinology and Metabolism, 2017, 102(9): 3461–3469
Deutschbein T, Reimondo G, Di Dalmazi G, et al. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. The Lancet. Diabetes & Endocrinology, 2022, 10(7): 499–508
Zeitzer J M, Nouriani B, Rissling M B, et al. Aberrant nocturnal cortisol and disease progression in women with breast cancer. Breast Cancer Research and Treatment, 2016, 158(1): 43–50
Sephton S E, Lush E, Dedert E A, et al. Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain, Behavior, and Immunity, 2013, 30 Suppl: S163-170
Innominato P F, Focan C, Gorlia T, et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Research, 2009, 69(11): 4700–4707
Ruan W, Yuan X, Eltzschig H K. Circadian rhythm as a therapeutic target. Nature Reviews. Drug Discovery, 2021, 20(4): 287–307
Razavi P, Devore E E, Bajaj A, et al. Shift work, chronotype, and melatonin rhythm in nurses. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2019, 28(7): 1177–1186
Green A, Cohen-Zion M, Haim A, et al. Evening light exposure to computer screens disrupts human sleep, biological rhythms, and attention abilities. Chronobiology International, 2017, 34(7): 855–865
Pickering L, Jennum P, Gammeltoft S, et al. Sleep-wake and melatonin pattern in craniopharyngioma patients. European Journal of Endocrinology, 2014, 170(6): 873–884
Pickering L, Main K M, Feldt-Rasmussen U, et al. Brain tumours in children and adolescents may affect the circadian rhythm and quality of life. Acta Paediatrica (Oslo, Norway: 1992), 2021, 110(12): 3376–3386
Joustra S D, Thijs R D, Van Den Berg R, et al. Alterations in diurnal rhythmicity in patients treated for nonfunctioning pituitary macroadenoma: a controlled study and literature review. European Journal of Endocrinology, 2014, 171(2): 217–228
Ciriello G, Miller M L, Aksoy B A, et al. Emerging landscape of oncogenic signatures across human cancers. Nature Genetics, 2013, 45(10): 1127–1133
Lourenco C, Resetca D, Redel C, et al. MYC protein interactors in gene transcription and cancer. Nature Reviews. Cancer, 2021, 21(9): 579–591
Altman B J, Hsieh A L, Sengupta A, et al. MYC disrupts the circadian clock and metabolism in cancer cells. Cell Metabolism, 2015, 22(6): 1009–1019
Haigis K M. KRAS alleles: the devil is in the detail. Trends in Cancer, 2017, 3(10): 686–697
Relógio A, Thomas P, Medina-Pérez P, et al. Ras-mediated deregulation of the circadian clock in cancer. PLoS Genetics, 2014, 10(5): e1004338
Qiu P, Jiang J, Liu Z, et al. BMAL1 knockout macaque monkeys display reduced sleep and psychiatric disorders. National Science Review, 2019, 6(1): 87–100
Ma S, Wang Z, Cao J, et al. BMAL1 but not clock is associated with monochromatic green light-induced circadian rhythm of melatonin in chick pinealocytes. Endocrine Connections, 2019, 8(1): 57–68
Bass A. Impact of kras and braf gene mutations on targeted therapies in colorectal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 2011, 29(19): 2728–2729
Chiodini I. Clinical review: diagnosis and treatment of subclinical hypercortisolism. The Journal of Clinical Endocrinology and Metabolism, 2011, 96(5): 1223–1236
Arendt J. Melatonin: countering chaotic time cues. Frontiers in Endocrinology, 2019, 10: 391
Dmitrzak-Weglarz M, Reszka E. Pathophysiology of depression: molecular regulation of melatonin homeostasis - current status. Neuropsychobiology, 2017, 76(3): 117–129
Innominato P F, Lim A S, Palesh O, et al. The effect of melatonin on sleep and quality of life in patients with advanced breast cancer. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 2016, 24(3): 1097–1105
Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. British Journal of Pharmacology, 2018, 175(16): 3190–3199
Palmer A C S, Zortea M, Souza A, et al. Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: a randomized, double-blind, placebo-controlled trial. PloS One, 2020, 15(4): e0231379
Madsen M T, Hansen M V, Andersen L T, et al. Effect of melatonin on sleep in the perioperative period after breast cancer surgery: a randomized, double-blind, placebo-controlled trial. Journal of clinical sleep medicine: JCSM: Official publication of the American Academy of Sleep Medicine, 2016, 12(2): 225–233
Melton L. Cognitive behavioral therapy for sleep in cancer patients: research, techniques, and individual considerations. Journal of the Advanced Practitioner in Oncology, 2018, 9(7): 732–740
Ma Y, Hall D L, Ngo L H, et al. Efficacy of cognitive behavioral therapy for insomnia in breast cancer: a meta-analysis. Sleep Medicine Reviews, 2021, 55: 101376
Masri S, Sassone-Corsi P. The emerging link between cancer, metabolism, and circadian rhythms. Nature Medicine, 2018, 24(12): 1795–1803
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
